Picture of Orgenesis logo

ORGS — Orgenesis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Orgenesis Inc reports results for the quarter ended in September - Earnings Summary

* Orgenesis Inc  ORGS.OQ  reported a quarterly adjusted loss
of 42 cents​​ per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 3 cents
per share.
* Revenue rose 401.8% to $8.68 million from a year ago; 
analysts expected $9.00 million. 
* Orgenesis Inc's reported EPS for the quarter was a loss of 42
cents​.
* The mean earnings estimate of analysts had risen by
about 86.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Orgenesis Inc shares had fallen by 3.2% this quarter and
gained 6.4% so far this year.
* The company reported a quarterly loss of $10.16 million.
* Wall Street's median 12-month price target for Orgenesis Inc
is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 4 at 02:00 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Orgenesis

See all news